Bio Developments

© Getty Images

Bio International 2024

Cytiva: 'BIO is a very important convention for us'

By Isabel Cameron

Life sciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for autologous CAR-T cell therapies. Find out more about the company's priorities, market challenges, expansion plans and more.

© Getty Images

Bio International 2024

Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024

By Isabel Cameron

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab Life Sciences to find out what the company is planning for the event and how it is navigating current challenges...

© Enhanc3D Genomics

How Hazel Jones is charting new horizons in genomics

By Isabel Cameron

Hazel Jones is the CEO at Enhanc3D Genomics. We sat down with her to discuss her leap of faith into 3D genomics, and how she is scaling the business and driving operational change.

© Getty Images

Nature Immunology spotlights Alchemab's cancer therapy potential

By Isabel Cameron

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, has published a peer-reviewed article titled "Predictability of B cell clonal persistence and immunosurveillance in breast...

© Getty Images

What innovations are reshaping the pharma services sector?

By Isabel Cameron

We sat down with Jay Ferguson, director at Houlihan Lokey's Healthcare Group, to discuss why he views the pharma services sector as a highly promising investment opportunity. He outlines his prediction that a confluence of tailwinds is set to sustain...

© Getty Images

CPHI North America 2024

Piramal Pharma unveils expanded services and growth vision

By Isabel Cameron

What is ADC specialist Piramal Pharma planning for the upcoming CPHI North America conference? We sat down with chief commercial officer Stuart Needleman to find out what's on the company's agenda.

© Getty Images

CPHI North America 2024

Selkirk Pharma: Adapting to regulatory shifts and market demand

By Isabel Cameron

Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.

Follow us

Webinars